Finally, we further validated the expression of GADD45B and PPP3CC in NSCLC using the TCGA database and KM survival curve analysis, and found that upregulated GADD45B and PPP3CC improved prognosis. The gene discussed is PPP3CC; the disease is non-small cell lung carcinoma.